International Clinical Trial: A Multicenter, Randomized, Single-Blind, Alteplase-Positive Controlled Phase ? Clinical Study to Evaluate the Efficacy and Safety of Recombinant Human Prourokinase for Injection (rhProuk) in the Treatment of Acute ST-Segment Elevation Myocardial Infarction (STEMI)

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119388) titled 'A Multicenter, Randomized, Single-Blind, Alteplase-Positive Controlled Phase ? Clinical Study to Evaluate the Efficacy and Safety of Recombinant Human Prourokinase for Injection (rhProuk) in the Treatment of Acute ST-Segment Elevation Myocardial Infarction (STEMI)' on Feb. 26.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: General Hospital of Northern Theater Command

Condition: Acute ST-Segment Elevation Myocardial Infarction

Intervention: Treatment Group- suraplase (rhProuk):rhProu with a specification of 1,000,000 IU per vial (6 vials for a single administration) shall be fully...